Archive The Faber Report

  Thursday, 4 Sep 2014 | 9:41 AM ET

Faber Report: Allergan special meeting coming

Posted ByDavid Faber
CNBC's David Faber reports another 2.8 percent of Allergan shareholders have sent in their consents to ask for a special meeting of shareholders. »Read more
  Friday, 22 Aug 2014 | 9:41 AM ET

Dynegy to buy assets from Duke Energy

Posted ByDavid Faber
CNBC's David Faber reports on a $6.25 billion deal between Dynegy and Duke Energy. »Read more
  Thursday, 21 Aug 2014 | 9:42 AM ET

Faber Report: Family Dollar rejects Dollar General's bid

Posted ByDavid Faber
CNBC's David Faber reports Family Dollar has rejected Dollar General's $78.50 per share bid over antitrust concerns. Family Dollar director and Trian Fund Management co-founder Ed Garden, shared his response. »Read more
  Wednesday, 20 Aug 2014 | 9:38 AM ET

Faber Report: WSJ says Allergan approaches Salix

Posted ByDavid Faber
CNBC's David Faber provides insight to news Allergan had approached Salix Pharma. »Read more
  Tuesday, 19 Aug 2014 | 9:41 AM ET

Faber Report: Family Dollar bid

Posted ByDavid Faber
CNBC's David Faber discusses the bidding war for Family Dollar. Faber reports the Family Dollar board is likely to meet this week to review Dollar General's bid, and will likely reject the offer. »Read more
  Friday, 15 Aug 2014 | 9:39 AM ET

Faber Report: Allergan shareholder shift

Posted ByDavid Faber
CNBC's David Faber reports the changes taking place at Allergan as 68 of its top 100 shareholders have sold down since March 31. »Read more
  Wednesday, 13 Aug 2014 | 9:40 AM ET

Faber Report: New wave of tax inversions?

Posted ByDavid Faber
CNBC's David Faber looks at whether the Treasury Department can do anything to stop company tax inversions; and looks at how some of the inversion deals are faring. »Read more
  Tuesday, 12 Aug 2014 | 9:39 AM ET

Faber Report: Hostile bids hard to do

Posted ByDavid Faber
CNBC's David Faber discusses just how hard hostiles are for companies to execute, after the canceled unsolicited bid between Time Warner and 21st Century Fox, and other companies recently. Faber provides an update on Valeant's battle for Allergan. »Read more
  Monday, 11 Aug 2014 | 9:46 AM ET

Faber Report: ValueAct's $1 billion 21st Century Fox stake

Posted ByDavid Faber
CNBC's David Faber shares his opinions of 21st Century Fox's decision to withdraw its bid in Time Warner; and discusses ValueAct Capital's large stake in 21st Century Fox. »Read more
  Wednesday, 30 Jul 2014 | 9:36 AM ET

Faber Report: Argentina negotiations begin

Posted ByDavid Faber
CNBC's David Faber and Jim Cramer discuss the increasing likelihood Argentina will default. »Read more